Pangaea Oncology SA logo

PANG - Pangaea Oncology SA News Story

€2 0.0  0.0%

Last Trade - 12/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £32.2m
Enterprise Value £35.0m
Revenue £3.52m
Position in Universe 507th / 726

BRIEF-Pangaea Oncology Signs Strategic Deal In Oncological Diagnosis With Qiagen

Mon 9th April, 2018 8:19am
April 9 (Reuters) - Pangaea Oncology SA  PANGO.MC :
    * SAYS SIGNS STRATEGIC AGREEMENT IN ONCOLOGICAL DIAGNOSIS
WITH
GERMAN DIAGNOSTIC MULTINATIONAL QIAGEN
    * SAYS DEAL HAS INITIAL DURATION OF THREE YEARS, EXTENDABLE
ANNUALLY BY MUTUAL AGREEMENT
    * AS FIRST STEP CO TO PERFORM QIAGEN TECHNOLOGY VALIDATION
TASKS
FOR DIAGNOSIS OF VARIOUS TUMOR TYPES
    * THIS CONTRACT IS FOR AN AMOUNT OF 149,000 EUROS OVER A
PERIOD OF
SIX MONTHS


Source text: https://bit.ly/2qiR1gq

Further company coverage:  PANGO.MC 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.